With the outbreak of Mpox in several countries, the demand for vaccines has increased. The vaccine, administered as a 2-dose ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

Youngsters have been especially impacted by mpox outbreaks raging in Africa, with children under five accounting for nearly a ...

The African health agency says that Rwanda has started a vaccination campaign against mpox with 1,000 doses it obtained from ...

Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in ...

(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II ...

On September 13, 2024, the World Health Organization (WHO) announced that it added the first vaccine against monkeypox (mpox) to its ...

In an emulated target trial, a single dose of modified vaccinia Ankara-Bavarian Nordic vaccine was moderately effective in ...

The World Health Organization (WHO) has announced the MVA-BN vaccine as the first vaccine against mpox to be added to its prequalification list.

However, only a few doses have reached Africa despite pleas from its governments. MVA-BN vaccine has already been used in Europe and the United States, the E.U. said, and it is authorized for use ...

4, 2024. (AP Photo/Moses Sawasawa) Mpox vaccine MVA-BN vaccine, manufactured by the Danish company Bavarian Nordic, are offloaded from a plane in Kinshasa, Congo, Thursday, Sept. 5, 2024.

The 100,000 doses of the MVA-BN vaccine, manufactured by the Danish company Bavarian Nordic, have been donated by the European Union through HERA, the bloc's agency for health emergencies.